Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
Rheumatology and Therapy|October 18, 2016
Rituximab for Rheumatoid ArthritisMarc D Cohen, Edward KeystoneCurrent Rheumatology Reports|August 20, 2013
Cell-signaling therapy in rheumatoid arthritisEdward Keystone, Marc D CohenCurrent Opinion in Rheumatology|April 15, 2009
Recent concepts in the inhibition of radiographic progression with biologicsEdward KeystoneThe Journal of Rheumatology. Supplement|November 7, 2007
Optimizing treatment with biologicsReuven Mader, Edward KeystoneRheumatic Diseases Clinics of North America|June 3, 2004
Adalimumab therapy in rheumatoid arthritisEdward Keystone, Boulos HaraouiCurrent Opinion in Rheumatology|December 14, 2005
Musculoskeletal manifestations and autoimmune diseases related to new biologic agentsBoulos Haraoui, Edward KeystoneExpert Opinion on Biological Therapy|July 11, 2015
Subcutaneous abatacept in rheumatoid arthritis: current updateEdward Keystone, Abdulaziz Alkhalaf, Mosaab MakkawyThe Journal of Rheumatology. Supplement|May 4, 2010
Optimizing use of tumor necrosis factor inhibitors in the management of immune-mediated inflammatory diseasesBrian Bressler, Boulos Haraoui, Edward Keystone, et al.Arthritis and Rheumatism|December 2, 2005
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposesFrederick Wolfe, Kaleb Michaud, Theodore Pincus, et al.Pageof 10